Correlation Between Tandem Diabetes and Clearpoint Neuro

Can any of the company-specific risk be diversified away by investing in both Tandem Diabetes and Clearpoint Neuro at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tandem Diabetes and Clearpoint Neuro into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tandem Diabetes Care and Clearpoint Neuro, you can compare the effects of market volatilities on Tandem Diabetes and Clearpoint Neuro and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tandem Diabetes with a short position of Clearpoint Neuro. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tandem Diabetes and Clearpoint Neuro.

Diversification Opportunities for Tandem Diabetes and Clearpoint Neuro

-0.01

Correlation Coefficient

Tandem Diabetes  Clearpoint Neuro

Good diversification

The 3 months correlation between Tandem and Clearpoint is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Tandem Diabetes Care and Clearpoint Neuro in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clearpoint Neuro and Tandem Diabetes is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tandem Diabetes Care are associated (or correlated) with Clearpoint Neuro. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clearpoint Neuro has no effect on the direction of Tandem Diabetes i.e., Tandem Diabetes and Clearpoint Neuro go up and down completely randomly.

Pair Corralation between Tandem Diabetes and Clearpoint Neuro

Given the investment horizon of 90 days Tandem Diabetes Care is expected to under-perform the Clearpoint Neuro. But the stock apears to be less risky and, when comparing its historical volatility, Tandem Diabetes Care is 1.17 times less risky than Clearpoint Neuro. The stock trades about -0.14 of its potential returns per unit of risk. The Clearpoint Neuro is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  1,262  in Clearpoint Neuro on September 3, 2024 and sell it today you would lose (25.00) from holding Clearpoint Neuro or give up 1.98% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Tandem Diabetes Care  vs.  Clearpoint Neuro

Tandem Diabetes Care

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tandem Diabetes Care has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Clearpoint Neuro

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Clearpoint Neuro has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Clearpoint Neuro is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Tandem Diabetes and Clearpoint Neuro

The main advantage of trading using opposite Tandem Diabetes and Clearpoint Neuro positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tandem Diabetes position performs unexpectedly, Clearpoint Neuro can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clearpoint Neuro will offset losses from the drop in Clearpoint Neuro's long position.

The idea behind Tandem Diabetes Care and Clearpoint Neuro pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.